clopidogrel has been researched along with Atheroembolism in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (85.71) | 29.6817 |
2010's | 2 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egbers, R; Helfrich, YR; Lowe, L; Tran, BA; Wang, F | 1 |
Hussein, A; Irani, F; Kasmani, R; Mohan, G | 1 |
Kartasheva, ED; Linchak, RM | 1 |
Schrör, K | 1 |
Füessl, HS | 1 |
Stiefelhagen, P | 1 |
Cannon, CP | 1 |
Faxon, DP; Nesto, RW | 1 |
Cho, JY; Jang, IJ; Kim, HS; Koo, BK; Lee, DS; Lee, MM; Park, KW; Sohn, DW; Suh, JW; Zhang, SY | 1 |
Michaud, V; Pharand, C; Turgeon, J | 1 |
Erdmann, E | 1 |
Guirguis, M | 1 |
Jamieson, DG | 1 |
Fintel, DJ | 1 |
3 review(s) available for clopidogrel and Atheroembolism
Article | Year |
---|---|
[The role of clopidogrel in the treatment and prevention of acute coronary syndrome and repetitive atherothrombotic events].
Topics: Acute Coronary Syndrome; Clopidogrel; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine; Treatment Outcome | 2010 |
Antiplatelet therapy in populations at high risk of atherothrombosis.
Topics: Arteriosclerosis; Aspirin; Chemoprevention; Clopidogrel; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine | 2006 |
Antiplatelet therapy in cerebrovascular disease: implications of Management of Artherothrombosis with Clopidogrel in High-risk Patients and the Clopidogrel for High Artherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance studies' resu
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stroke; Ticlopidine | 2007 |
2 trial(s) available for clopidogrel and Atheroembolism
Article | Year |
---|---|
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.
Topics: Aged; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Embolism, Cholesterol; Enzyme Inhibitors; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Factors; Thrombosis; Ticlopidine | 2006 |
[Prevention of atherothrombotic incidents. CHARISMA Study (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance].
Topics: Aged; Aspirin; Cause of Death; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Embolism, Cholesterol; Female; Humans; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2006 |
9 other study(ies) available for clopidogrel and Atheroembolism
Article | Year |
---|---|
Cholesterol embolization syndrome with an atypical proximal presentation simulating calciphylaxis.
Topics: Aspirin; Back; Buttocks; Calciphylaxis; Cardiac Catheterization; Clopidogrel; Diagnosis, Differential; Embolism, Cholesterol; Erythema; Female; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Skin Ulcer; Thigh; Ticlopidine | 2014 |
Athero-embolic isolated splenic infarction following left cardiac catheterization.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aortic Aneurysm, Abdominal; Aspirin; Atherosclerosis; Cardiac Catheterization; Clopidogrel; Coronary Stenosis; Embolism, Cholesterol; Heparin; Humans; Infarction; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Spleen; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2009 |
[Current pharmacological principles to inhibit platelet function and their clinical implications. Focus on clopidogrel].
Topics: Aspirin; Clopidogrel; Embolism, Cholesterol; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 2004 |
[Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
Topics: Arterial Occlusive Diseases; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Intracranial Embolism; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2004 |
[Primary and secondary prevention of stroke. Prevention is better than healing].
Topics: Aged; Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Secondary Prevention; Ticlopidine | 2004 |
Cost-effectiveness of clopidogrel.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Cost-Benefit Analysis; Embolism, Cholesterol; Humans; Myocardial Infarction; Ticlopidine | 2004 |
Understanding clopidogrel efficacy in the presence of cytochrome P450 polymorphism.
Topics: Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Factors; Thrombosis; Ticlopidine | 2006 |
Atherothrombotic events and clopidogrel therapy.
Topics: Aged; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Embolism, Cholesterol; Enzyme Inhibitors; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Factors; Thrombosis; Ticlopidine | 2007 |
Update on the use of antiplatelet agents in secondary stroke prevention.
Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine | 2007 |